Cargando…
Racial differences in longitudinal toxicities of anticancer agents in early phase cancer clinical trials
BACKGROUND: Racial differences have been reported in toxicity outcomes for anticancer drug treatments. However, these observations were often from studies with small sample sizes, and many only reported the maximum grade of toxicity and no longitudinal information. This current analysis aims to inve...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524029/ https://www.ncbi.nlm.nih.gov/pubmed/37519123 http://dx.doi.org/10.1002/cam4.6370 |